SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 102 filers reported holding SYROS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $93,000 | +322.7% | 96,651 | +418.6% | 0.00% | – |
| Q1 2022 | $22,000 | -85.0% | 18,636 | -5.2% | 0.00% | – |
| Q1 2021 | $147,000 | -49.7% | 19,668 | -26.9% | 0.00% | -100.0% |
| Q4 2020 | $292,000 | -28.8% | 26,897 | -41.9% | 0.00% | 0.0% |
| Q3 2020 | $410,000 | -1.7% | 46,331 | +18.4% | 0.00% | 0.0% |
| Q2 2020 | $417,000 | +379.3% | 39,128 | +167.5% | 0.00% | – |
| Q1 2020 | $87,000 | – | 14,629 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|